RT Journal Article
SR Electronic
T1 Early neurodevelopmental problems and risk for avoidant/restrictive food intake disorder (ARFID) in the general child population: a Japanese birth cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.08.21265646
DO 10.1101/2021.11.08.21265646
A1 Dinkler, Lisa
A1 Yasumitsu-Lovell, Kahoko
A1 Eitoku, Masamitsu
A1 Fujieda, Mikiya
A1 Suganuma, Narufumi
A1 Hatakenaka, Yuhei
A1 Hadjikhani, Nouchine
A1 Bryant-Waugh, Rachel
A1 Råstam, Maria
A1 Gillberg, Christopher
YR 2021
UL http://medrxiv.org/content/early/2021/11/11/2021.11.08.21265646.abstract
AB Background An overrepresentation of neurodevelopmental disorders (NDDs) has been observed in individuals with avoidant/restrictive food intake disorder (ARFID). Previous studies on the association between ARFID and NDDs are limited to cross-sectional data from clinical samples of small size. This study aimed to extend previous research by using prospectively collected data in children from a general population sample. We examined the occurrence and predictive power of early neurodevelopmental problems in 4–7-year-old children with suspected ARFID.Methods Data were collected via parent-report in 3,728 children born between 2011 and 2014 in Kochi prefecture, a sub-sample of the Japan Environment and Children’s Study (JECS). Neurodevelopmental problems were assessed with several instruments at different time points between 0.5 and 3 years of age as part of the JECS. In an add-on study, ARFID was identified cross-sectionally (between 4 and 7 years of age) using a newly developed screening tool.Results Circa 3% of children at high risk for NDDs in preschool age screened positive for ARFID between age 4 and 7 years, reflecting a three times increased risk of suspected ARFID. A fifth (20.8%) of children with suspected ARFID had likely NDDs, compared to 8.6% of children without suspected ARFID. Developmental delay trajectories of children with and without suspected ARFID started to divert after the age of 6 months. Only 2.2% of children with early feeding problems later screened positive for ARFID. The inclusion of neurodevelopmental problems improved the prediction of later ARFID.Conclusions The results mirror the previously observed overrepresentation of NDDs in ARFID populations, although to a weaker extent. In non-clinical populations, early feeding problems are common and rarely develop into ARFID, however, our findings imply that they should be monitored closely in children with high neurodevelopmental risk in order to prevent ARFID.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swedish Research Council (M.R., 2018-02544; C.G., 538-2013-8864), Torsten Soederbergs Foundation (C.G., M151/14), AnnMari and Per Ahlqvist Foundation (C.G., 2018), Japan Society for the Promotion of Science (M.F., 18KK0263), Scandinavia-Japan Sasakawa Foundation (L.D., 2016), Samariten Foundation (L.D., 2017-0283), Wilhelm and Martina Lundgrens Foundation (L.D., 2017-1738), Petter Silfverskioelds Memorial Foundation (L.D., 2017-093 & 2018-142), Professor Bror Gadelius Memorial Foundation (L.D., 2019 & 2020), and Solstickan Foundation (L.D., 2020). The Japan Environment and Children's Study was funded by the Ministry of the Environment, Japan. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The findings and conclusions of this article are solely the responsibility of the authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee at Kochi Medical School (ERB-102925 and ERB-104083).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are unsuitable for public deposition due to ethical restrictions and legal framework of Japan. It is prohibited by the Act on the Protection of Personal Information (Act No. 57 of 30 May 2003, amendment on 9 September 2015) to publicly deposit the data containing personal information. Ethical Guidelines for Medical and Health Research Involving Human Subjects enforced by the Japan Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare also restricts the open sharing of the epidemiologic data. All inquiries about access to data should be sent to: jecs-en@nies.go.jp. The person responsible for handling enquiries sent to this e-mail address is Dr Shoji F. Nakayama, JECS Programme Office, National Institute for Environmental Studies.ADHDAttention-Deficit/Hyperactivity DisorderASDAutism Spectrum DisorderARFIDAvoidant/Restrictive Food Intake DisorderESSENCE-QEarly Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations-QuestionnaireASQ-3Ages and Stages Questionnaire-3JECSJapan Environment and Children’s StudyNDDNeurodevelopmental disorder